J Korean Neurosurg Soc.  2014 Aug;56(2):79-85. 10.3340/jkns.2014.56.2.79.

Sarcopenia and Neurosurgery

• Park SW

• KMID: 1956507
• DOI: http://doi.org/10.3340/jkns.2014.56.2.79

Abstract

Aging process can be characterized as a spontaneous decrease of function in various organs with age. Muscle, as a big organ of human body, undergoes aging process presenting with loss of muscle mass, "sarcopenia". Recently, several working groups have tried to make consensus about sarcopenia for definition and diagnosis. Muscle mass is known to be closely related with bone, brain, fat, cardiovascular and metabolic systems. With increased understanding, clinical and basic researches about sarcopenia have been also increased rapidly from various areas of health science and technology. In this paper, the history and recent concepts of sarcopenia were reviewed and brief discussion of its prospect in the field of neurosurgery was done.

Keyword

Aging; Muscles; Sarcopenia; Consensus; Stroke; Spine

MeSH Terms

Aging
Brain
Consensus
Diagnosis
Human Body
Muscles
Neurosurgery*
Sarcopenia*
Spine
Stroke

Figure

• 

  Fig. 1 Diagnostic algorithm suggested by the European Working Group on Sarcopenia in Older People for elderly individuals (>65 years) or younger individuals at risk.

• 

  Fig. 2 Diagnostic algorithm suggested by the Asian Working Group for Sarcopenia for old people according to the definition of elderly in each country

Reference

1. Arasaki K, Igarashi O, Ichikawa Y, Machida T, Shirozu I, Hyodo A, et al. Reduction in the motor unit number estimate (MUNE) after cerebral infarction. J Neurol Sci. 2006; 250:27–32. PMID: 16904126.

2. Baccarelli A, Morpurgo PS, Corsi A, Vaghi I, Fanelli M, Cremonesi G, et al. Activin A serum levels and aging of the pituitary-gonadal axis : a cross-sectional study in middle-aged and elderly healthy subjects. Exp Gerontol. 2001; 36:1403–1412. PMID: 11602213.

3. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147:755–763. PMID: 9554417.

4. Binkley N, Buehring B. Beyond FRAX : it's time to consider "sarco-osteopenia". J Clin Densitom. 2009; 12:413–416. PMID: 19733110.

5. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D : a meta-analysis of randomised controlled trials. BMJ. 2009; 339:b3692. PMID: 19797342.

6. Bowser M, Herberg S, Arounleut P, Shi X, Fulzele S, Hill WD, et al. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol. 2013; 48:290–297. PMID: 23178301.

7. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007; 317:807–810. PMID: 17690295.

8. Buehring B, Krueger D, Binkley N. Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J Cachexia Sarcopenia Muscle. 2013; 4:47–54. PMID: 22872366.

9. Campion DR, Richardson RL, Reagan JO, Kraeling RR. Changes in the satellite cell population during postnatal growth of pig skeletal muscle. J Anim Sci. 1981; 52:1014–1018. PMID: 7240043.

10. Candow DG, Chilibeck PD. Effect of creatine supplementation during resistance training on muscle accretion in the elderly. J Nutr Health Aging. 2007; 11:185–188. PMID: 17435961.

11. Carda S, Cisari C, Invernizzi M. Sarcopenia or muscle modifications in neurologic diseases : a lexical or patophysiological difference? Eur J Phys Rehabil Med. 2013; 49:119–130. PMID: 23575206.

12. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol. 1999; 277(2 Pt 2):R601–R606. PMID: 10444569.

13. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, et al. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005; 82:428–434. PMID: 16087989.

14. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia : consensus report of the asian working group for sarcopenia. J Am Med Dir Assoc. 2014; 15:95–101. PMID: 24461239.

15. Choi KM. Sarcopenia and sarcopenic obesity. Endocrinol Metab (Seoul). 2013; 28:86–89. PMID: 24396659.

16. Chrusch MJ, Chilibeck PD, Chad KE, Davison KS, Burke DG. Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc. 2001; 33:2111–2117. PMID: 11740307.

17. Cianferotti L, Brandi ML. Muscle-bone interactions : basic and clinical aspects. Endocrine. 2014; 45:165–177. PMID: 23990248.

18. Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci. 2008; 63:829–834. PMID: 18772470.

19. Coin A, Perissinotto E, Enzi G, Zamboni M, Inelmen EM, Frigo AC, et al. Predictors of low bone mineral density in the elderly : the role of dietary intake, nutritional status and sarcopenia. Eur J Clin Nutr. 2008; 62:802–809. PMID: 17637603.

20. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412–423. PMID: 20392703.

21. De Deyne PG, Hafer-Macko CE, Ivey FM, Ryan AS, Macko RF. Muscle molecular phenotype after stroke is associated with gait speed. Muscle Nerve. 2004; 30:209–215. PMID: 15266637.

22. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007; 55:769–774. PMID: 17493199.

23. DiGirolamo DJ, Kiel DP, Esser KA. Bone and skeletal muscle : neighbors with close ties. J Bone Miner Res. 2013; 28:1509–1518. PMID: 23630111.

24. Doherty TJ, Vandervoort AA, Brown WF. Effects of ageing on the motor unit : a brief review. Can J Appl Physiol. 1993; 18:331–358. PMID: 8275048.

25. Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL, et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol (1985). 2008; 104:1452–1461. PMID: 18323467.

26. Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, et al. The activin A-follistatin system : potent regulator of human extracellular matrix mineralization. FASEB J. 2007; 21:2949–2960. PMID: 17449718.

27. Elkasrawy MN, Hamrick MW. Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010; 10:56–63. PMID: 20190380.

28. Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr. 1993; 123(2 Suppl):465–468. PMID: 8429405.

29. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia : a new definition. Clin Nutr. 2008; 27:793–799. PMID: 18718696.

30. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 1990; 263:3029–3034. PMID: 2342214.

31. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults : evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56:M146–M156. PMID: 11253156.

32. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack : a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42:227–276. PMID: 20966421.

33. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab. 2009; 297:E157–E164. PMID: 19435857.

34. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults : the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006; 61:1059–1064. PMID: 17077199.

35. Grimby G, Saltin B. The ageing muscle. Clin Physiol. 1983; 3:209–218. PMID: 6347501.

36. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, et al. Lower extremity function and subsequent disability : consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000; 55:M221–M231. PMID: 10811152.

37. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function : association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994; 49:M85–M94. PMID: 8126356.

38. Guth L, Samaha FJ. Qualitative differences between actomyosin ATPase of slow and fast mammalian muscle. Exp Neurol. 1969; 25:138–152. PMID: 4241609.

39. Hamrick MW. The skeletal muscle secretome : an emerging player in muscle-bone crosstalk. Bonekey Rep. 2012; 1:60. PMID: 23951457.

40. Hikida RS. Aging changes in satellite cells and their functions. Curr Aging Sci. 2011; 4:279–297. PMID: 21529324.

41. Hoffman JR, Kraemer WJ, Bhasin S, Storer T, Ratamess NA, Haff GG, et al. Position stand on androgen and human growth hormone use. J Strength Cond Res. 2009; 23(5 Suppl):S1–S59. PMID: 19620932.

42. Honda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr. 2007; 86:633–638. PMID: 17823427.

43. Hyun SJ, Bae CW, Lee SH, Rhim SC. Fatty degeneration of paraspinal muscle in patients with the degenerative lumbar kyphosis : a new evaluation method of quantitative digital analysis using MRI and CT scan. J Spinal Disord Tech. 2013; [Epub ahead of print].

44. Hyun SJ, Kim YB, Kim YS, Park SW, Nam TK, Hong HJ, et al. Postoperative changes in paraspinal muscle volume : comparison between paramedian interfascial and midline approaches for lumbar fusion. J Korean Med Sci. 2007; 22:646–651. PMID: 17728503.

45. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes : clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007; 55:780–791. PMID: 17493201.

46. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004; 159:413–421. PMID: 14769646.

47. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002; 50:889–896. PMID: 12028177.

48. Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One. 2009; 4:e7038. PMID: 19753111.

49. Kim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status : the Korean Sarcopenic Obesity Study. Clin Endocrinol (Oxf). 2013; 78:525–532. PMID: 22563924.

50. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes : the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010; 33:1497–1499. PMID: 20413515.

51. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults : the Korean sarcopenic obesity study. Int J Obes (Lond). 2009; 33:885–892. PMID: 19564878.

52. Kullberg S, Ramírez-León V, Johnson H, Ulfhake B. Decreased axosomatic input to motoneurons and astrogliosis in the spinal cord of aged rats. J Gerontol A Biol Sci Med Sci. 1998; 53:B369–B379. PMID: 9754135.

53. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility : an operational diagnosis of sarcopenia. J Appl Physiol (1985). 2003; 95:1851–1860. PMID: 14555665.

54. Lee JC, Cha JG, Kim Y, Kim YI, Shin BJ. Quantitative analysis of back muscle degeneration in the patients with the degenerative lumbar flat back using a digital image analysis : comparison with the normal controls. Spine (Phila Pa 1976). 2008; 33:318–325. PMID: 18303466.

55. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A. 2005; 102:18117–18122. PMID: 16330774.

56. Léger B, Derave W, De Bock K, Hespel P, Russell AP. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 2008; 11:163B–175B. PMID: 18240972.

57. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995; 50(Spec No):11–16. PMID: 7493202.

58. Lynch NA, Ryan AS, Evans J, Katzel LI, Goldberg AP. Older elite football players have reduced cardiac and osteoporosis risk factors. Med Sci Sports Exerc. 2007; 39:1124–2230. PMID: 17596780.

59. Mangione KK, Miller AH, Naughton IV. Cochrane review : improving physical function and performance with progressive resistance strength training in older adults. Phys Ther. 2010; 90:1711–1715. PMID: 21123213.

60. Mannion AF, Taimela S, Müntener M, Dvorak J. Active therapy for chronic low back pain part 1 Effects on back muscle activation, fatigability, and strength. Spine (Phila Pa 1976). 2001; 26:897–908. PMID: 11317112.

61. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 1961; 9:493–495. PMID: 13768451.

62. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387:83–90. PMID: 9139826.

63. Melton LJ 3rd, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000; 48:625–630. PMID: 10855597.

64. Mengiardi B, Schmid MR, Boos N, Pfirrmann CW, Brunner F, Elfering A, et al. Fat content of lumbar paraspinal muscles in patients with chronic low back pain and in asymptomatic volunteers : quantification with MR spectroscopy. Radiology. 2006; 240:786–792. PMID: 16926328.

65. Min SH, Kim MH, Seo JB, Lee JY, Lee DH. The quantitative analysis of back muscle degeneration after posterior lumbar fusion : comparison of minimally invasive and conventional open surgery. Asian Spine J. 2009; 3:89–95. PMID: 20404953.

66. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc. 2010; 11:391–396. PMID: 20627179.

67. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001; 137:231–243. PMID: 11283518.

68. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus : a call to action. J Am Med Dir Assoc. 2013; 14:392–397. PMID: 23764209.

69. Needham D. Red and white muscle. Physiol Rev. 1926; 6:1–28.

70. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia : alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51:1602–1609. PMID: 14687390.

71. Ochi M, Kohara K, Tabara Y, Kido T, Uetani E, Ochi N, et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis. 2010; 212:327–332. PMID: 20554280.

72. Ochi M, Tabara Y, Kido T, Uetani E, Ochi N, Igase M, et al. Quadriceps sarcopenia and visceral obesity are risk factors for postural instability in the middle-aged to elderly population. Geriatr Gerontol Int. 2010; 10:233–243. PMID: 20199590.

73. Ormsbee MJ, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A, et al. Osteosarcopenic obesity : the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle. 2014; [Epub ahead of print].

74. Pannérec A, Marazzi G, Sassoon D. Stem cells in the hood : the skeletal muscle niche. Trends Mol Med. 2012; 18:599–606. PMID: 22877884.

75. Pedersen BK. The diseasome of physical inactivity--and the role of myokines in muscle fat cross talk. J Physiol. 2009; 587(Pt 23):5559–5568. PMID: 19752112.

76. Pedersen BK, Edward F. Adolph distinguished lecture : muscle as an endocrine organ : IL-6 and other myokines. J Appl Physiol (1985). 2009; 107:1006–1014. PMID: 19696361.

77. Peter JB, Barnard RJ, Edgerton VR, Gillespie CA, Stempel KE. Metabolic profiles of three fiber types of skeletal muscle in guinea pigs and rabbits. Biochemistry. 1972; 11:2627–2633. PMID: 4261555.

78. Quinn TJ, Paolucci S, Sunnerhagen KS, Sivenius J, Walker MF, Toni D, et al. Evidence-based stroke rehabilitation : an expanded guidance document from the european stroke organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008. J Rehabil Med. 2009; 41:99–111. PMID: 19225703.

79. Rosenberg IH. Sarcopenia : origins and clinical relevance. Clin Geriatr Med. 2011; 27:337–339. PMID: 21824550.

80. Rosenberg IH. Summary comments : epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr. 1989; 50:1231–1233.

81. Roubenoff R. Catabolism of aging : is it an inflammatory process? Curr Opin Clin Nutr Metab Care. 2003; 6:295–299. PMID: 12690262.

82. Roubenoff R. Sarcopenic obesity : the confluence of two epidemics. Obes Res. 2004; 12:887–888. PMID: 15229325.

83. Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women : relationships with metabolic cardiovascular disease risk factors. Int J Obes Relat Metab Disord. 1999; 23:126–132. PMID: 10078845.

84. Sato K, Iemitsu M, Aizawa K, Ajisaka R. Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab. 2008; 294:E961–E968. PMID: 18349113.

85. Sayer AA, Syddall HE, Dennison EM, Martin HJ, Phillips DI, Cooper C, et al. Grip strength and the metabolic syndrome : findings from the Hertfordshire Cohort Study. QJM. 2007; 100:707–713. PMID: 17951315.

86. Scherbakov N, von Haehling S, Anker SD, Dirnagl U, Doehner W. Stroke induced Sarcopenia : muscle wasting and disability after stroke. Int J Cardiol. 2013; 170:89–94. PMID: 24231058.

87. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007; 102:919–925. PMID: 17095641.

88. Stenholm S, Rantanen T, HeliÖvaara M, Koskinen S. The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc. 2008; 56:462–469. PMID: 18179481.

89. Tan BH, Fearon KC. Cachexia : prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008; 11:400–407. PMID: 18541999.

90. Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA, Peterson CA. Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev. 2002; 123:649–661. PMID: 11850028.

91. Theou O, Jones GR, Overend TJ, Kloseck M, Vandervoort AA. An exploration of the association between frailty and muscle fatigue. Appl Physiol Nutr Metab. 2008; 33:651–665. PMID: 18641707.

92. Visser M, Deeg DJ, Lips P. Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia) : the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003; 88:5766–5772. PMID: 14671166.

93. Vlassopoulos A, Combet E, Lean ME. Changing distributions of body size and adiposity with age. Int J Obes (Lond). 2014; 38:857–864. PMID: 24247373.

94. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005; 90:2787–2793. PMID: 15728213.

95. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J. 2009; 73:13–18. PMID: 19043226.

96. Wang ZM, Visser M, Ma R, Baumgartner RN, Kotler D, Gallagher D, et al. Skeletal muscle mass : evaluation of neutron activation and dual-energy X-ray absorptiometry methods. J Appl Physiol (1985). 1996; 80:824–831. PMID: 8964743.

97. Watts NB. The Fracture Risk Assessment Tool (FRAX®) : applications in clinical practice. J Womens Health Larchmt. 2011; 20:525–531. PMID: 21438699.

98. Wehling M, Cai B, Tidball JG. Modulation of myostatin expression during modified muscle use. FASEB J. 2000; 14:103–110. PMID: 10627285.

99. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. 2003; 58:618–625. PMID: 12865477.

100. Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons : time to be moving. J Gerontol A Biol Sci Med Sci. 2008; 63:160–164. PMID: 18314451.

101. Yarasheski KE, Pak-Loduca J, Hasten DL, Obert KA, Brown MB, Sinacore DR. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men >/= 76 yr old. Am J Physiol. 1999; 277(1 Pt 1):E118–E125. PMID: 10409135.

102. Yoo SH, Kim JS, Kwon SU, Yun SC, Koh JY, Kang DW. Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients. Arch Neurol. 2008; 65:39–43. PMID: 18195138.

103. Zadik Z, Chalew SA, McCarter RJ Jr, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 1985; 60:513–516. PMID: 3972964.

104. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity : a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008; 18:388–395. PMID: 18395429.